ARCA BIOPHARMA INC (ABIO)

US00211Y5069 - Common Stock

3.58  +0.1 (+2.87%)

Premarket: 3.53 -0.05 (-1.4%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
7.30M10.60M19.34M9.77M5.81M
Research and Development
1.01M4.75M13.83M4.99M1.83M
Selling, General, and Administrative Expenses
6.28M5.85M5.50M4.77M3.98M
Operating Income
-7.30M-10.60M-19.34M-9.77M-5.81M
Interest Income/Expense
1.96M675.00K13.00K20.00K170.00K
Other Income/Expense
0.00-5.00KN/AN/AN/A
Income Before Taxes
-5.34M-9.93M-19.32M-9.75M-5.65M
Income Tax
N/AN/A0.00-10.00K-170.00K
Net Income
-5.34M-9.93M-19.32M-9.74M-5.48M
EBITDA
-7.28M-10.58M-19.32M-9.76M-5.79M
 
Per Share Data
EPS Diluted Total Ops
-0.37-0.69-1.39-2.07-4.15
Non GAAP EPS
N/AN/AN/A-2.50-4.53
 
Statistics

All data in USD

Charts